Fields »
ABOUT
HELP
BLOG

379 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
VesiclesTissue enhanced
EPORErythropoietin receptorCancer-related genes
Disease related genes
FDA approved drug targets
Predicted membrane proteins
VesiclesTissue enhanced
ERBB2Erb-b2 receptor tyrosine kinase 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol		Expressed in all
ERBB4Erb-b2 receptor tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
F2RCoagulation factor II (thrombin) receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FADS1Fatty acid desaturase 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FADS2Fatty acid desaturase 2Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
FCER1AFc fragment of IgE, high affinity I, receptor for; alpha polypeptideFDA approved drug targets
Predicted membrane proteins
Mixed
FCER1GFc fragment of IgE, high affinity I, receptor for; gamma polypeptideFDA approved drug targets
Predicted membrane proteins
Expressed in all
FCGR1AFc fragment of IgG, high affinity Ia, receptor (CD64)CD markers
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
FCGR1BFc fragment of IgG, high affinity Ib, receptor (CD64)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
FCGR2AFc fragment of IgG, low affinity IIa, receptor (CD32)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FCGR2BFc fragment of IgG, low affinity IIb, receptor (CD32)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FCGR3BFc fragment of IgG, low affinity IIIb, receptor (CD16b)CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
FFAR1Free fatty acid receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
NucleoliExpressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesMixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Endoplasmic reticulumTissue enriched
FGFR4Fibroblast growth factor receptor 4Cancer-related genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
FKBP1AFK506 binding protein 1A, 12kDaEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
MicrotubulesExpressed in all
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Actin filaments		Tissue enriched
FLT3Fms-related tyrosine kinase 3Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Endoplasmic reticulumTissue enhanced
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cell Junctions		Mixed
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
FSHRFollicle stimulating hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
FXYD2FXYD domain containing ion transport regulator 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
GABBR1Gamma-aminobutyric acid (GABA) B receptor, 1FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
CentrosomeTissue enhanced
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA2Gamma-aminobutyric acid (GABA) A receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA3Gamma-aminobutyric acid (GABA) A receptor, alpha 3FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRA4Gamma-aminobutyric acid (GABA) A receptor, alpha 4FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRA5Gamma-aminobutyric acid (GABA) A receptor, alpha 5FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Cell JunctionsTissue enriched
GABRA6Gamma-aminobutyric acid (GABA) A receptor, alpha 6FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
GABRB1Gamma-aminobutyric acid (GABA) A receptor, beta 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
GABRB2Gamma-aminobutyric acid (GABA) A receptor, beta 2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GABRB3Gamma-aminobutyric acid (GABA) A receptor, beta 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GABRDGamma-aminobutyric acid (GABA) A receptor, deltaDisease related genes
FDA approved drug targets
Predicted membrane proteins
Golgi apparatus
Vesicles		Tissue enriched
GABREGamma-aminobutyric acid (GABA) A receptor, epsilonFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GABRG1Gamma-aminobutyric acid (GABA) A receptor, gamma 1FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRG2Gamma-aminobutyric acid (GABA) A receptor, gamma 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GABRG3Gamma-aminobutyric acid (GABA) A receptor, gamma 3FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
GABRPGamma-aminobutyric acid (GABA) A receptor, piFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
GABRQGamma-aminobutyric acid (GABA) A receptor, thetaFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
GABRR1Gamma-aminobutyric acid (GABA) A receptor, rho 1FDA approved drug targets
Predicted membrane proteins
Tissue enriched
GABRR2Gamma-aminobutyric acid (GABA) A receptor, rho 2FDA approved drug targets
Predicted membrane proteins
Not detected
GABRR3Gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene)FDA approved drug targets
Predicted membrane proteins
Not detected
GCGRGlucagon receptorFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatusGroup enriched

« prev | Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.